Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesHuman Airway Contraction and Formoterol-induced Relaxation is Determined by Ca2+ Oscillations and Ca2+ Sensitivity
American Journal of Respiratory Cell and Molecular Biology, 09/23/09
Ressmeyer AR et al. – Formoterol induces long–lasting relaxation by initially reducing the Ca2+ sensitivity and, subsequently, the frequency of the Ca2+ oscillations of the airway SMCs.
Related Articles
Combination of Formoterol and Tiotropium in the Treatment of COPD: Effects on Lung Function
COPD: Journal of Chronic Obstructive Pulmonary Disease, 10/06/09
Relevance Score: 91%
Budesonide/formoterol effects on metalloproteolytic balance in TGF-beta-activated human lung fibroblasts
Respiratory Medicine, 10/13/09
Relevance Score: 87%
Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events
Cochrane Reviews, 10/20/09
Relevance Score: 85%
Budesonide/formoterol pressurized metered-dose inhaler: a guide to its use in asthma
Drugs & Therapy Perspectives, 10/16/09
Relevance Score: 84%
Budesonide/formoterol maintenance and reliever therapy versus conventional best practice
Respiratory Medicine, 10/13/09
Relevance Score: 84%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Inhaled Corticosteroids Should Be Initiated Before Discharge from the Emergency Department in Patients with Persistent Asthma
Journal of Asthma, 12/15/09
Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma
European Respiratory Journal , 12/15/09
Comparison of chemotherapy regimens for concurrent chemoradiotherapy in unresectable stage III non-small cell lung cancer
International Journal of Clinical Oncology, 12/15/09
Sponsor
Article Search
Sponsor
Sponsor